SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-225902
Filing Date
2008-11-05
Accepted
2008-11-05 16:29:46
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 441006
2 FOURTH AMENDMENT TO LEASE dex102.htm EX-10.2 16731
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9315
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9215
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4479
  Complete submission text file 0001193125-08-225902.txt   482160
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 081164118
SIC: 2836 Biological Products, (No Diagnostic Substances)